Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans

Clinical Infectious Diseases

Volumn 44, Issue 12, 2007, Pages 1639-1646

  Rangaka, Molebogeng X ^a,c   Diwakar, Lavanya ^a   Seldon, Ronnett ^a   Van Cutsem, Gilles ^c   Meintjes, Graeme A ^a,d   Morroni, Chelsea ^b   Mouton, Priscilla ^a,c   Shey, Muki S ^a   Maartens, Gary ^a,b   Wilkinson, Katalin A ^a,e   Wilkinson, Robert J ^a,b,d,e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c GF Jooste Hospital ^*  (South Africa)

^d GF Jooste Hospital   (South Africa)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; GAMMA INTERFERON; TUBERCULIN;

ADULT; AFRICAN AMERICAN; ANTIGEN SPECIFICITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN TARGETING; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, BACTERIAL; CD4 LYMPHOCYTE COUNT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; SOUTH AFRICA; T-LYMPHOCYTES; TUBERCULIN TEST; TUBERCULOSIS;

EID: 34249888790     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/518234     Document Type: Article

References (40)

1. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163:1009-21.
2. Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 2000; 23:75-80.
3. Elliott AM, Hodsdon WS, Kyosiimire J, et al. Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Trans R Soc Trop Med Hyg 2004; 98:660-70.
4. Silveira H, Ordway D, Dockrell H, Jackson M, Ventura F. Cell-mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection. Clin Exp Immunol 1997; 110: 26-34.
5. Elliott AM, Hurst TJ, Balyeku MN, et al. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study. Int J Tuberc Lung Dis 1999; 3:239-47.
6. Wallis RS, Vjecha M, Amir-Tahmasseb M, et al. Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis. J Infect Dis 1993; 167:43-8.
7. Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis - specific T cells. AIDS 2002; 16:2285-93.
8. Rangaka MX, Wilkinson KA, Seldon R, et al. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007; 175:514-20.
9. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996; 178:1274-82.
10. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995; 63:1710-7.
11. Berthet FX, Rasmussen PB, Rosenkrands I, Andersen P, Gicquel B. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 1998; 144:3195-203.
12. Lalvani A, Pathan AA, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Resp Crit Care Med 2001; 163:824-8.
13. Liebeschuetz S, Bamber S, Ewer K, Decks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004; 364:2196-203.
14. Nicol MP, Pienaar D, Wood K, et al. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis 2005; 40:1301-8.
15. Lalvani A, Pathan AA, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001; 357:2017-21.
16. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361:1168-73.
17. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United Stales. MMWR Recomm Rep 2005; 54:49-55.
18. Johnson JL, Nyole S, Okwera A, et al. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration. Am J Respir Crit Care Med 1998; 158:1790-6.
19. StopTBpartnership. The global plan to stop TB: Executive summary. 2006. Available at: http://www.stoptb.org/globalplan/plan_main.asp. Accessed 6 May 2007.
20. Scholvinck E, Wilkinson KA, Whelan AO, Martineau AR, Levin M, Wilkinson RJ. Gamma interferon-based immunodiagnosis of tuberculosis: comparison between whole-blood and enzyme-linked immunospot methods. J Clin Microbiol 2004; 42:829-31.
21. Wilkinson KA, Simsova M, Scholvinck E, et al. Efficient ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids. Infect Immun 2005; 73:2991-8.
22. Skjot RL, Brock I, Arend SM, et al. Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family. Infect Immun 2002; 70:5446-53.
23. Hogarth PJ, Logan KE, Vordermeier HM, Singh M, Hewinson RG, Chambers MA. Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c - a member of the esat-6 gene family. Vaccine 2005; 23:2557-64.
24. Wilkinson KA, Stewart GR, Newton SM, et al. Infection biology of a novel α-crystallin of Mycobacterium tuberculosis: Acr2. J Immunol 2005; 174:4237-43.
25. Stewart GR, Newton SM, Wilkinson KA, et al. The stress-responsive chapcrone alpha-crystallin 2 is required for pathogenesis of Mycobacterium tuberculosis. Mol Microbiol 2005; 55:1127-37.
26. Mohammed A, Ehrlich R, Wood R, Cilliers F, Maartens G. Screening for tuberculosis in adults with advanced HIV infection prior to preventive therapy. Int J Tuberc Lung Dis 2004; 8:792-5.
27. Mosimaneotsile B, Talbot EA, Moeti TL, et al. Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana. Lancet 2003; 362:1551-2.
28. Wilkinson KA, Kon OM, Newton SM, et al. Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J Infect Dis 2006; 193:354-9.
29. Wilkinson KA, Wilkinson RJ, Pathan A, et al. Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin Infect Dis 2005; 40:184-7.
30. GraphPad software Web site. Available at: http://www.graphpad.com. Accessed 25 April 2007.
31. Lalvani A. Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin Infect Dis 2004; 38: 757-9.
32. Jeffries DJ, Hill PC, Fox A, et al. Identifying ELISPOT and skin test cut-offs for diagnosis of Mycobacterium tuberculosis infection in The Gambia. Int J Tuberc Lung Dis 2006; 10:192-8.
33. Vordermeier HM, Chambers MA, Cockle PJ, Whelan AO, Simmons J, Hewinson RG. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 2002; 70:3026-32.
34. Dietrich J, Aagaard C, Leah R, et al. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol 2005; 174:6332-9.
35. Lalvani A, Nagvenkar P, Udwadia Z, et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001; 183:469-477.
36. Verver S, Warren RM, Munch Z, et al. Transmission of tuberculosis in a high incidence urban community in South Africa. Int J Epidemiol 2004; 33:351-7.
37. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18:887-95.
38. Corbett EL, Charalambous S, Moloi VM, et al. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med 2004; 170:673-9.
39. Lawn SD, Bekker LG, Middelkoop K, Myer L, Wood R. Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. Clin Infect Dis 2006; 42:1040-7.
40. Young D, Dye C. The development and impact of tuberculosis vaccines. Cell 2006; 124:683-7.